Artiva Biotherapeutics Inc (ARTV)
3.28 -0.26 (-7.34%) 12:46 ET [NASDAQ]
3.25 x 36 3.33 x 100
Realtime by (Cboe BZX)
3.25 x 36 3.33 x 100
Realtime - - (-) -
for Fri, Mar 28th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 09-2024 | 06-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -49,278 | -31,806 | N/A | -16,722 |
| Depreciation Amortization | N/A | 1,817 | 1,190 | N/A | 1,672 |
| Accounts receivable | N/A | 465 | 465 | N/A | -1,612 |
| Accounts payable and accrued liabilities | N/A | 601 | -103 | N/A | 1,514 |
| Other Working Capital | N/A | -14 | -3,023 | N/A | -27,193 |
| Other Operating Activity | 0 | 6,027 | 4,506 | 0 | 5,586 |
| Operating Cash Flow | $N/A | $-40,382 | $-28,771 | $N/A | $-36,755 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -118,919 | 11,613 | N/A | -20,685 |
| PPE Investments | N/A | -578 | -482 | N/A | -2,622 |
| Investing Cash Flow | $N/A | $-119,497 | $11,131 | $N/A | $-23,307 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 23,431 |
| Debt Repayment | N/A | -116 | -78 | N/A | N/A |
| Common Stock Issued | N/A | 166,535 | 22 | N/A | 10 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -12 |
| Other Financing Activity | 0 | -4,163 | -1,560 | 0 | 0 |
| Financing Cash Flow | $N/A | $162,256 | $-1,616 | $N/A | $23,429 |
| Beginning Cash Position | N/A | 53,762 | 53,762 | N/A | 102,776 |
| End Cash Position | N/A | 56,139 | 34,506 | N/A | 66,143 |
| Net Cash Flow | $N/A | $2,377 | $-19,256 | $N/A | $-36,633 |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | -40,382 | -28,771 | N/A | -36,755 |
| Capital Expenditure | N/A | -578 | -482 | N/A | -2,622 |
| Free Cash Flow | 0 | -40,960 | -29,253 | 0 | -39,377 |